Skip to main content
. Author manuscript; available in PMC: 2021 Aug 21.
Published in final edited form as: ACS Chem Biol. 2020 Aug 12;15(8):2137–2153. doi: 10.1021/acschembio.0c00339

Table 1.

Effects of chemical perturbations

Compound Target and Mode of Action Primary Cellular Effects Connection to α-Synuclein Hypothesized Effects on α-Synuclein Fitness Landscape
Dopamine Covalent modification of α-synuclein41 Neurotransmitter α-Synuclein deficiency alters dopamine signaling;12 dopaminergic neurons degenerate selectively in PD;29 dopamine promotes oligomer formation, inhibits fibrillization41 Residues that interact with dopamine will show disruptive mutations selectively in the presence of dopamine; sequence signatures of oligomers (e.g., positions sensitive to steric hindrance) will emerge
Menadione Quinone reduction by molecular oxygen generates superoxide radicals Induces oxidative stress Various α-synuclein species induce oxidative stress;42 oxidative modification of α-synuclein is observed in patients43 and inhibits fibrillization;44 menadione exacerbates α-synuclein toxicity in yeast45 Residues whose oxidation contributes to α-synuclein toxicity will become more sensitive to mutation; compromised capacity to resolve oxidative stress might reveal conformations that drive toxicity by increasing oxidative stress
Melatonin Scavenges free radicals Relieves oxidative stress Various α-synuclein species induce oxidative stress;42 oxidative modification of α-synuclein is observed in patients43 and inhibits fibrillization;44 melatonin attenuates α-synuclein toxicity in yeast challenged by menadione45 Residues that become modified by oxidative stress will be less sensitive to mutation; enhanced resilience to oxidative stress might reveal conformations that drive toxicity through other mechanisms
Miconazole Inhibits 14α-sterol demethylase, reducing ergosterol production46 Decreases membrane sterol content, affecting membrane fluidity and integrity46 Sterol content modulates the membrane-binding affinity of α-synuclein47 Membrane-contacting residues will be selectively affected; cells might maintain resistance only to variants with the weakest membrane affinity
Brefeldin A Inhibits COP-I coat assembly Disrupts Golgi-ER and other membrane transport processes; induces the unfolded protein response ER-Golgi trafficking genes modify α-synuclein toxicity;20 α-synuclein inclusions involve clustered ER/Golgi vesicles18,19 Because cells will be more sensitive to agents that interfere with trafficking, cells should be more sensitive to all variants except those with the weakest membrane affinity, which are less likely to affect trafficking; sequence signatures of alternatively localized α-synuclein should emerge
MG-132 Covalent inhibitor of the 20S proteasome Reduces degradation of ubiquitin-modified proteins Lewy bodies are enriched in ubiquitinated proteins, including α-synuclein;48 ubiquitination is a common cellular strategy for mitigating misfolded proteins; α-synuclein impairs proteasome function49 Residues whose ubiquitination modifies α-synuclein toxicity will be less sensitive to mutation; species that are more efficiently ubiquitinated and cleared will become apparent
Tunicamycin Inhibits glycosyl-transferases involved in glycoprotein synthesis50 Creates a burden of misfolded ER proteins; induces the unfolded protein response50 α-Synuclein accumulation induces the unfolded protein response;21 α-synuclein interferes with glycoprotein maturation;21 tunicamycin induces α-synuclein oligomerization in cellular models36 Cells will become less resistant to all variants except those with the weakest membrane affinity, which are less likely to affect glycoprotein maturation; additional sequence determinants of oligomerization might appear; sequence determinants of species resolved by the unfolded protein response will appear
Geldanamycin ADP/ATP-competitive inhibitor of Hsp9051 Reduces proteostatic capacity51 Hsp90 reduces α-synuclein aggregation and toxicity by modifying oligomers52 Sequence signatures of conformations resolved by Hsp90 will appear; residues that directly interact with Hsp90 will be less sensitive to mutation
Rapamycin Inhibitor of mTORC1 formation53 Inhibits translation; induces autophagy53 α-Synuclein aggregates are cleared by autophagy;37 α-synuclein aggregation impairs autophagy54 Variants with sub-saturating toxicity will increase in fitness due to reduced translation; residues that mediate trafficking to autophagosomes will be more sensitive to mutation; sequence signatures of toxic species not resolved by autophagy will be revealed
Spermidine Inhibits histone acetyltransferases, altering the epigenetic state of histone H3 and inducing transcription of autophagy-related genes55 Induces autophagy; suppresses oxidative stress55 α-Synuclein aggregates are cleared by autophagy;37 synuclein aggregation impairs autophagy54 Residues that mediate trafficking to autophagosomes will be more sensitive to mutation; sequence signatures of toxic species not resolved by autophagy will be revealed